Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricSNYSanofi SAGSKGSK plcBMYBristol Myers Squibb
Snapshot
Price$43.73$50.83$60.77
Market cap$98.73B$102.51B$118.71B
Valuation
P/E7.4x13.8x20.6x
Forward P/E5.3x9.8x16.3x
Growth
Revenue growth43.7%4.0%1.8%
EPS growth96.2%86.7%26.3%
Profitability
Net margin17.2%17.8%12.3%
ROE17.0%35.8%41.6%
Balance sheet & cash
Debt / equity0.28x1.08x2.44x
Free cash flow yield21.4%3.8%15.4%
Dividend yield5.4%3.5%4.5%
Verdict
Investment ratingStrong· 80Favorable· 66Favorable· 60

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearSNYtoday $44GSKtoday $51BMYtoday $61
2027$64.35 – $94.38+116% CAGR$71.19 – $104.41+105% CAGR$57.55 – $84.41+39% CAGR
2028$126.25 – $185.17+106% CAGR$132.93 – $194.96+96% CAGR$72.67 – $106.58+32% CAGR
2029$247.71 – $363.30+103% CAGR$248.21 – $364.05+93% CAGR$91.76 – $134.58+30% CAGR
2030$486.00 – $712.80+101% CAGR$463.49 – $679.78+91% CAGR$115.86 – $169.93+29% CAGR
2031$953.53 – $1,398.52+100% CAGR$865.47 – $1,269.36+90% CAGR$146.30 – $214.58+29% CAGR
5-yr CAGR85.2% – 100.0%76.3% – 90.3%19.2% – 28.7%